To address whether anti-CCAR1 antibodies are uniquely found in DM patients, or are also found in other autoimmune diseases known to have an association with malignancy, 68 sera from anti-POLR3A–positive scleroderma patients were assayed. Here, POLR3A is linked to scleroderma.